Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : Expects Nearly $2 Billion Covid-19 Revenue Impact in 2020

07/31/2020 | 07:42am EDT

By Matt Grossman

 

Merck & Co. Inc. on Friday narrowed and raised its full-year financial guidance to levels that exceeded analysts' expectations for revenue and adjusted profit, but noted the effects of the Covid-19 pandemic are likely to hurt its full-year revenue figure by nearly $2 billion.

The company expects to report full-year revenue of $47.2 billion to $48.7 billion, and a profit of $4.58 a share to $4.73 a share. On an adjusted basis, Merck expects a profit of $5.63 a share to $5.78 a share.

Analysts had forecast full-year adjusted earnings of $5.31 a share, and revenue of $47.2 billion, according to FactSet.

Merck's guidance includes its estimate that the pandemic will have a full-year negative revenue impact of $1.95 billion.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

All news about MERCK & CO., INC.
04:06pSECTOR UPDATE : Health Care Stocks Closing Slightly Higher
MT
01:41pSECTOR UPDATE : Health Care Stocks Inching Higher This Afternoon
MT
12:47pMERCK : weighed down by charges in Q2, but drug sales rebound
AQ
12:33pMERCK : Announces Appointment of Cristal N. Downing as Chief Communications & Pu..
BU
09:54aMERCK : Reports Higher Second-Quarter Results But Mixed Against Street Views, Na..
MT
09:06aSECTOR UPDATE : Health Care Stocks Cautiously Up Ahead of Thursday's Opening Bel..
MT
08:51aToday on Wall Street: GDP growth misses estimates
07:17aMERCK : 2Q21 Merck Earnings Presentation
PU
07:17aMERCK : 2Q21 Merck Other Financial Disclosures
PU
07:12aMERCK : Posts Higher Q2 Earnings, Sales; Revises 2021 Outlook
MT
More news
Financials (USD)
Sales 2021 46 318 M - -
Net income 2021 12 867 M - -
Net Debt 2021 11 044 M - -
P/E ratio 2021 16,7x
Yield 2021 3,34%
Capitalization 198 B 198 B -
EV / Sales 2021 4,52x
EV / Sales 2022 4,10x
Nbr of Employees 73 500
Free-Float 70,7%
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MRK | US58933Y1055 | MarketScreener
Technical analysis trends MERCK & CO., INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 78,33 $
Average target price 94,32 $
Spread / Average Target 20,4%
EPS Revisions
Managers and Directors
Robert M. Davis President, Chief Executive Officer & Director
Caroline A. Litchfield Chief Financial Officer & Executive Vice President
Kenneth C. Frazier Executive Chairman
Sandy Tremps Vice President-R&D IT CIO
Dave Williams Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
MERCK & CO., INC.-4.24%198 336
JOHNSON & JOHNSON9.40%453 418
ROCHE HOLDING AG12.49%332 374
PFIZER, INC.18.04%243 220
ELI LILLY AND COMPANY46.00%224 084
NOVARTIS AG0.39%223 750